Key result
The authors argue that the universal recommendation for intravenous over oral furosemide in acute decompensated heart failure lacks evidence and suggest trials on larger oral doses.
Why the study?
Does intravenous furosemide improve outcomes compared to oral furosemide in patients with acute decompensated congestive cardiac failure?
Does intravenous furosemide improve outcomes compared to oral furosemide in patients with acute decompensated congestive cardiac failure?
No takes yet. Share an insight, caveat, or question.
The authors argue that the universal guideline recommendation for intravenous over oral furosemide in acute decompensated heart failure lacks robust evidence and call for trials investigating larger oral doses.
MacAllister et al. (2015) conducted an editorial in Acute decompensated congestive heart failure. Intravenous furosemide vs. Oral furosemide was evaluated. The authors argue that the universal recommendation for intravenous over oral furosemide in acute decompensated heart failure lacks evidence and suggest trials on larger oral doses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: